Income Taxes (Details Narrative) - USD ($) |
12 Months Ended | |||
|---|---|---|---|---|
Dec. 22, 2017 |
Dec. 31, 2018 |
Dec. 31, 2017 |
Dec. 31, 2016 |
|
| Valuation allowance | $ 7,340,511 | $ 6,004,605 | ||
| Change in valuation allowance | 1,335,000 | |||
| Operating loss carryforwards for federal and state income tax | $ 24,237,000 | |||
| Expiration of operating loss carryforwards | Dec. 31, 2034 | |||
| Number of common shares issued | 312,500 | 1,777,417 | ||
| Annual limitation of net operating loss through 2021 | $ 1,800,000 | |||
| Annual limitation of net operating loss after 2021 | $ 273,000 | |||
| Income tax description | As a result of the Tax Act, the U.S. statutory tax rate was lowered from 35% to 21% effective January 1, 2018, among other changes. ASC Topic 740 requires companies to recognize the effect of tax law changes in the period of enactment; therefore, the Company was required to revalue its deferred tax liabilities at the new rate. As a result of the reduction in the U.S. corporate income tax rate, we re-measured our ending net deferred tax liabilities at December 31, 2017 at the rate at which they are expected to reverse in the future and recognized a tax benefit of $788,000. | |||
| Corporate tax rate | 9.70% | 7.30% | ||
| Tax benefit re-measured amount | $ 788,000 | |||
| Undistributed foreign e&p amount | $ 332,000 | |||
| U.S. Tax Cuts and Jobs Act of 2017 [Member] | ||||
| Corporate tax rate | 35.00% | 21.00% | ||
| X | ||||||||||
- Definition Annual limitation of net operating loss after year five. No definition available.
|
| X | ||||||||||
- Definition Annual limitation of net operating loss through year five. No definition available.
|
| X | ||||||||||
- Definition Tax benefit remeasured amount. No definition available.
|
| X | ||||||||||
- Definition Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition A brief description of status of the tax examination, significant findings to date, and the entity's position with respect to the findings. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to repatriation of foreign earnings. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Expiration date of each operating loss carryforward included in operating loss carryforward, in CCYY-MM-DD format. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|